Catalyst Pharmaceuticals, Inc.

Informe acción NasdaqCM:CPRX

Capitalización de mercado: US$2.5b

Salud financiera de hoja de balance de Catalyst Pharmaceuticals

Salud financiera controles de criterios 6/6

Catalyst Pharmaceuticals tiene un patrimonio de accionistas total de $660.9M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $772.0M y $111.1M respectivamente. El BAIT de Catalyst Pharmaceuticals es de $174.0M, por lo que su ratio de cobertura de intereses es de -13.5. Tiene efectivo e inversiones a corto plazo que ascienden a $442.3M.

Información clave

0%

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de intereses-13.5x
EfectivoUS$442.33m
PatrimonioUS$660.94m
Total pasivoUS$111.07m
Activos totalesUS$772.01m

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

We Think Catalyst Pharmaceuticals' (NASDAQ:CPRX) Profit Is Only A Baseline For What They Can Achieve

Nov 13
We Think Catalyst Pharmaceuticals' (NASDAQ:CPRX) Profit Is Only A Baseline For What They Can Achieve

Market Participants Recognise Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Earnings

Nov 07
Market Participants Recognise Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Earnings

Earnings Tell The Story For Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

Jul 24
Earnings Tell The Story For Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

Catalyst Pharmaceuticals: New Products In Proving Phase

Jul 06

Catalyst Pharmaceuticals: Revenue Growth Lagging Expense Growth (Rating Downgrade)

Apr 06

Earnings Tell The Story For Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

Jan 29
Earnings Tell The Story For Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

Catalyst Pharmaceuticals: Until The TEVA ANDA Is Resolved, There Is A Risk

Jan 17

With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Makes An Interesting Case

Sep 06
With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Makes An Interesting Case

Should You Be Adding Catalyst Pharmaceuticals (NASDAQ:CPRX) To Your Watchlist Today?

May 27
Should You Be Adding Catalyst Pharmaceuticals (NASDAQ:CPRX) To Your Watchlist Today?

Do Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings Warrant Your Attention?

Feb 13
Do Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings Warrant Your Attention?

Is Now The Time To Put Catalyst Pharmaceuticals (NASDAQ:CPRX) On Your Watchlist?

Nov 11
Is Now The Time To Put Catalyst Pharmaceuticals (NASDAQ:CPRX) On Your Watchlist?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($539.0M) de CPRX superan a sus pasivos a corto plazo ($105.4M).

Pasivo a largo plazo: Los activos a corto plazo de CPRX ($539.0M) superan a sus pasivos a largo plazo ($5.7M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: CPRX está libre de deudas.

Reducción de la deuda: CPRX no ha tenido ninguna deuda en los últimos 5 años.

Cobertura de la deuda: CPRX no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.

Cobertura de intereses: CPRX no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.


Hoja de balance


Descubre empresas con salud financiera